Fina BioSolutions, China National Pharmaceutical Group Corp. deal

Fina granted the Chengdu Institute of Biological Products Co. Ltd. rights in China to use Fina's conjugate vaccine technology to develop and commercialize pneumococcal vaccines. Fina is eligible for u...